BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hesamizadeh K, Sharafi H, Keyvani H, Alavian SM, Shabankareh AN-T, Olyaie RS, Keshvari M. Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran. Hepat Mon. 2016;16:e32215. [PMID: 27110256 DOI: 10.5812/hepatmon.32215] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 El-kafrawy SA, El-daly MM. Hepatitis E virus in Saudi Arabia: more surveillance needed. Future Virology. [DOI: 10.2217/fvl-2021-0320] [Reference Citation Analysis]
2 Badur S, Öztürk S, AbdelGhany M, Khalaf M, Lagoubi Y, Ozudogru O, Hanif K, Saha D. Hepatitis A in the Eastern Mediterranean Region: a comprehensive review. Hum Vaccin Immunother 2022;:2073146. [PMID: 35617508 DOI: 10.1080/21645515.2022.2073146] [Reference Citation Analysis]
3 Cheung CKM, Wong SH, Law AWH, Law MF. Transfusion-transmitted hepatitis E: What we know so far? World J Gastroenterol 2022;28:47-75. [PMID: 35125819 DOI: 10.3748/wjg.v28.i1.47] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hadifar S, Sedighi M, Mostafaei S, Miri A, Amiri H, Abiri R, Babaei F, Kabir K, Moghoofei M. Prevalence of hepatitis E infection in the general population of Iran: a systematic review and meta-analysis. Future Virology 2017;12:227-36. [DOI: 10.2217/fvl-2016-0112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
5 Kumar H, Kamar N, Kumar D. Hepatitis E: Current Status in India and Other Asian Countries. J Pure Appl Microbiol 2019;13:141-59. [DOI: 10.22207/jpam.13.1.15] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Ferreira VL, Souza VRD, Araujo Muzzillo D, Pontarolo R. Prevalence of Hepatitis E Virus Antibodies Among Blood Donors: A Systematic Review and Meta-Analysis. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.42875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
7 Shahriarirad R, Erfani A, Rastegarian M, Zeighami A, Arefkhah N, Ghorbani F, Sarvari J, Sarkari B. Seroprevalence of anti-hepatitis E antibodies and antigens among HIV-infected patients in Fars Province, southern Iran. Virol J 2020;17:109. [PMID: 32680534 DOI: 10.1186/s12985-020-01384-0] [Reference Citation Analysis]
8 Safiabadi M, Rezaee-zavareh MS, Moayed Alavian S. Estimation of Hepatitis A Virus Infection Prevalence Among Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Pooled Analysis. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.44695] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
9 Shiukhi S, Elikaei A, Sharifi Z. The Prevalence of Hepatitis A Among Blood Donors in Golestan Province in the Northeast of Iran. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.81609] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Villalba R, Mirabet V. Risk assessment of hepatitis E transmission through tissue allografts. World J Gastrointest Pathophysiol 2022; 13(2): 50-58 [DOI: 10.4291/wjgp.v13.i2.50] [Reference Citation Analysis]
11 Tripathy AS, Puranik S, Sharma M, Chakraborty S, Devakate UR. Hepatitis E virus seroprevalence among blood donors in Pune, India. J Med Virol 2019;91:813-9. [PMID: 30489644 DOI: 10.1002/jmv.25370] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Taherkhani R, Farshadpour F. Epidemiology of hepatitis E virus in Iran. World J Gastroenterol 2016; 22(22): 5143-5153 [PMID: 27298557 DOI: 10.3748/wjg.v22.i22.5143] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
13 Ghasemian R, Babamahmoodi F, Ahangarkani F. Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report. Hepat Mon 2016;16:e38138. [PMID: 27630729 DOI: 10.5812/hepatmon.38138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Süer K, Güvenir M, Aykaç A. A Special Risk Group for Hepatitis E Infection: The First Record of North Cyprus. Pol J Microbiol 2018;67:525-8. [PMID: 30550239 DOI: 10.21307/pjm-2018-062] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Zangi M, Khodabandehloo M, Mohammadi S, Nouri B. The Seroprevalence of Hepatitis A Virus (HAV) Among Blood Donors Presenting to the Iranian Blood Transfusion Organization in Sanandaj, Iran. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.110357] [Reference Citation Analysis]
16 Zeraati AA, Nazemian F, Takalloo L, Sahebkar A, Heidari E, Yaghoubi MA. The relationship between serology of hepatitis E virus with liver and kidney function in kidney transplant patients. EXCLI J 2016;15:343-9. [PMID: 27366144 DOI: 10.17179/excli2016-232] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Akbarpour Shirazi M, Samieifard R, Abduli MA, Omidvar B. Mathematical modeling in municipal solid waste management: case study of Tehran. J Environ Health Sci Eng 2016;14:8. [PMID: 27195124 DOI: 10.1186/s40201-016-0250-2] [Cited by in Crossref: 12] [Article Influence: 2.0] [Reference Citation Analysis]
18 Pourkarim MR, Thijssen M, Alavian SM, Van Ranst M. Natural disasters pose a challenge for hepatitis elimination in Iran. Lancet Gastroenterol Hepatol 2019;4:581-2. [PMID: 31292070 DOI: 10.1016/S2468-1253(19)30197-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Maponga TG, Lopes T, Cable R, Pistorius C, Preiser W, Andersson MI. Prevalence and risks of hepatitis E virus infection in blood donors from the Western Cape, South Africa. Vox Sang 2020;115:695-702. [PMID: 32597542 DOI: 10.1111/vox.12966] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Behzadi MA, Leyva-Grado VH, Namayandeh M, Ziyaeyan A, Feyznezhad R, Dorzaban H, Jamalidoust M, Ziyaeyan M. Seroprevalence of viral hepatitis A, B, C, D and E viruses in the Hormozgan province southern Iran. BMC Infect Dis 2019;19:1027. [PMID: 31795979 DOI: 10.1186/s12879-019-4661-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]